What is ME/CFS Phase III Ampligen Study?

Category: Others

false

The ME/CFE Phase III Ampligen Study is a clinical trial looking at the treatment of severely debilitating chronic fatigue syndrome with ampligen infusions.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
0
None
2

Commonly reported side effects and conditions associated with ME/CFS Phase III Ampligen Study

Side effect Patients
Occasional flu like symptoms 1
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 0
Not specified 1
Last updated:
There are no evaluations for ME/CFS Phase III Ampligen Study.